Journal Title：Molecular Cancer

Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.

《分子癌癥》從分子角度促進癌癥和相關(guān)生物醫(yī)學科學領(lǐng)域思想、概念和發(fā)現(xiàn)的交流?！斗肿影┌Y》對基礎(chǔ)、轉(zhuǎn)化和臨床研究的文章感興趣，為理解、預防、診斷和治療癌癥開辟了新途徑。感興趣的主題包括但不限于：細胞和腫瘤生物學、血管生成、動物模型、轉(zhuǎn)移、癌癥抗原及其免疫反應、細胞信號傳導和分子生物學、流行病學、癌癥和分子靶點的遺傳和分子分析、癌癥干細胞、DNA 損傷和修復、細胞周期、細胞凋亡、分子病毒學以及基于疫苗和抗體的癌癥療法。

Molecular Cancer創(chuàng)刊于2002年，由BioMed Central出版商出版，收稿方向涵蓋醫(yī)學 - 生化與分子生物學全領(lǐng)域，在行業(yè)領(lǐng)域中學術(shù)影響力很大，屬于TOP期刊，國際一流期刊，關(guān)注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關(guān)注此刊。平均審稿速度 約2月 ，影響因子指數(shù)27.7，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。